Factors associated with poor immune reconstitution at last follow-up
| Variables . | Crude OR* (95% CI) . | P† . |
|---|---|---|
| CD4 T-cell count | ||
| Host chimerism | 5.4 (1.1-27) | .04 |
| Low CD4+ T-cell count 1 y after HSCT | 15.9 (3.8-66) | < .001 |
| Low CD4+ T-cell count 2 y after HSCT | 11 (3.2-41) | < .001 |
| Immunoglobulin substitution | ||
| Molecular diagnosis | .05 | |
| Rag-1/2 deficiency | 1 | |
| Artemis deficiency | 13 (1.2-129) | .03‡ |
| γ c/Jak3 deficiency | 12 (1.5-99) | .02‡ |
| Others | 1.8 (0.1-32) | .7‡ |
| Host chimerism | 5.6 (1.2-86) | .03 |
| Immunoglobulin substitution 2 y after HSCT | 22 (5.6-86) | < .001 |
| Variables . | Crude OR* (95% CI) . | P† . |
|---|---|---|
| CD4 T-cell count | ||
| Host chimerism | 5.4 (1.1-27) | .04 |
| Low CD4+ T-cell count 1 y after HSCT | 15.9 (3.8-66) | < .001 |
| Low CD4+ T-cell count 2 y after HSCT | 11 (3.2-41) | < .001 |
| Immunoglobulin substitution | ||
| Molecular diagnosis | .05 | |
| Rag-1/2 deficiency | 1 | |
| Artemis deficiency | 13 (1.2-129) | .03‡ |
| γ c/Jak3 deficiency | 12 (1.5-99) | .02‡ |
| Others | 1.8 (0.1-32) | .7‡ |
| Host chimerism | 5.6 (1.2-86) | .03 |
| Immunoglobulin substitution 2 y after HSCT | 22 (5.6-86) | < .001 |